AmCham's Healthcare Committee brings together a diverse group of member companies involved in innovative healthcare who aim to contribute to the quality, efficacy and efficiency of the Dutch healthcare system by creating an optimal environment for innovation, private initiative, and public-private collaboration. Key focus areas of AmCham's Healthcare Committee are digitalization, value-based healthcare and an optimal business climate for healthcare companies operating in the Netherlands.
In September 2022, the Healthcare Committee published the report 'Let's Connect' on the value of health solutions companies for the Netherlands.
Participating Companies
- Abbott
- AbbVie
- Amgen
- AstraZeneca
- Biogen
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Gilead
- GSK
- Johnson and Johnson
- Lilly
- Medtronic
- Moderna
- MSD
- Pfizer
- Stryker
- Vertex
